Patrick M. Schlievert
Oprichter bij Hennepin Life Sciences LLC
Actieve functies van Patrick M. Schlievert
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Hennepin Life Sciences LLC
 Hennepin Life Sciences LLC Pharmaceuticals: MajorHealth Technology Hennepin Life Sciences LLC operates as a clinical-stage biotechnology company which focuses on identifying and developing antimicrobial therapeutics. It is advancing its novel antimicrobial, GML Gel, for local administration to prevent and treat CA-UTIs caused by ESKAPE pathogens in hospitals and long-term care centers. The company was founded by Patrick M. Schlievert, William Merrill Faulkner and Douglas Wicks in 2009 and is headquartered in Plymouth, MN. | Directeur/Bestuurslid | 01-01-2009 | - |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2009 | - | |
| Oprichter | 01-01-2009 | - |
Loopbaan van Patrick M. Schlievert
Eerdere bekende functies van Patrick M. Schlievert
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
ImmuVen, Inc.
 ImmuVen, Inc. Drugstore ChainsRetail Trade ImmuVen, Inc. develops drugs to treat viral diseases and cancer. The firm develops biotherapeutics to treat cancer, infectious disease, and autoimmune disorders. It’s platform allows rapid selection and optimization of T cell receptors with high affinity to targets in cancer, infections, and autoimmune pathways. The company was founded by David Kranz and Patrick M Schlievert in November 2008 and is headquartered in Champaign, IL. | Oprichter | 01-11-2008 | - |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Retail Trade | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
ImmuVen, Inc.
ImmuVen, Inc. Drugstore ChainsRetail Trade ImmuVen, Inc. develops drugs to treat viral diseases and cancer. The firm develops biotherapeutics to treat cancer, infectious disease, and autoimmune disorders. It’s platform allows rapid selection and optimization of T cell receptors with high affinity to targets in cancer, infections, and autoimmune pathways. The company was founded by David Kranz and Patrick M Schlievert in November 2008 and is headquartered in Champaign, IL. | Retail Trade |
Hennepin Life Sciences LLC
Hennepin Life Sciences LLC Pharmaceuticals: MajorHealth Technology Hennepin Life Sciences LLC operates as a clinical-stage biotechnology company which focuses on identifying and developing antimicrobial therapeutics. It is advancing its novel antimicrobial, GML Gel, for local administration to prevent and treat CA-UTIs caused by ESKAPE pathogens in hospitals and long-term care centers. The company was founded by Patrick M. Schlievert, William Merrill Faulkner and Douglas Wicks in 2009 and is headquartered in Plymouth, MN. | Health Technology |
